JUNIE TILUS: Open Payments
NPI 1275032377 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 75 payments from 19 companies in 2025. Trend: 2023 $656 · 2024 $1,894 · 2025 $1,851
Food & beverage: $1,724Education: $127
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $311 |
| UCB, Inc. | 9 | $224 |
| ABBVIE INC. | 9 | $213 |
| GENZYME CORPORATION | 6 | $196 |
| Janssen Biotech, Inc. | 14 | $191 |
| STRATA Skin Sciences, Inc. | 3 | $156 |
| LEO Pharma Inc. | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Lilly USA, LLC | 3 | $69 |
| Galderma Laboratories, L.P. | 3 | $67 |
Products named: DUPIXENT, Bimzelx, TREMFYA, XTRAC, SKYRIZI, RINVOQ, NEMLUVIO, ADBRY.
Industry payments across FL — which companies pay providers there.
